Kerecis Omega3 Surgiclose
Payments companies reported to CMS as associated with Kerecis Omega3 Surgiclose. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Kerecis Omega3 Surgiclose, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Kerecis Omega3 Surgiclose
These are the largest totals companies reported as associated with Kerecis Omega3 Surgiclose. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Robert Kirsner | Miami, FL | Dermatology | $3,265,217.64 |
| Michael Lacqua | Brooklyn, NY | Plastic Surgery | $1,442,057.71 |
| Alfredo Cordova | Sarasota, FL | Surgical Critical Care | $380,903.55 |
| Marcus Duda | Greensboro, NC | Orthopaedic Surgery | $363,940.38 |
| Sai Ramakrishna Velamuri Venkata | Tampa, FL | Plastic and Reconstructive Surgery | $315,032.21 |
| Mark Suski | Thousand Oaks, CA | Plastic and Reconstructive Surgery | $301,223.21 |
| Karl Stark | North Kansas City, MO | Vascular Surgery | $269,438.82 |
| Marcus Yarbrough | Virginia Beach, VA | General Practice | $261,941.75 |
| Salvatore Pacella | San Diego, CA | Plastic Surgery | $243,908.97 |
| John Lantis | New York, NY | Vascular Surgery | $228,137.15 |
Prescribed Kerecis Omega3 Surgiclose?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.